Menu
GeneBe

11-108354756-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000051.4(ATM):​c.8787-55C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.563 in 1,417,564 control chromosomes in the GnomAD database, including 227,018 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.54 ( 22541 hom., cov: 33)
Exomes 𝑓: 0.57 ( 204477 hom. )

Consequence

ATM
NM_000051.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.70
Variant links:
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]
C11orf65 (HGNC:28519): (chromosome 11 open reading frame 65) Predicted to be involved in negative regulation of mitochondrial fission and negative regulation of protein targeting to mitochondrion. Predicted to be located in cytosol and mitochondrial outer membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 11-108354756-C-T is Benign according to our data. Variant chr11-108354756-C-T is described in ClinVar as [Benign]. Clinvar id is 1177616.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-108354756-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.631 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ATMNM_000051.4 linkuse as main transcriptc.8787-55C>T intron_variant ENST00000675843.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ATMENST00000675843.1 linkuse as main transcriptc.8787-55C>T intron_variant NM_000051.4 P1

Frequencies

GnomAD3 genomes
AF:
0.537
AC:
81656
AN:
151924
Hom.:
22528
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.416
Gnomad AMI
AF:
0.644
Gnomad AMR
AF:
0.624
Gnomad ASJ
AF:
0.640
Gnomad EAS
AF:
0.435
Gnomad SAS
AF:
0.649
Gnomad FIN
AF:
0.630
Gnomad MID
AF:
0.747
Gnomad NFE
AF:
0.569
Gnomad OTH
AF:
0.568
GnomAD4 exome
AF:
0.566
AC:
716048
AN:
1265522
Hom.:
204477
AF XY:
0.570
AC XY:
365143
AN XY:
640216
show subpopulations
Gnomad4 AFR exome
AF:
0.412
Gnomad4 AMR exome
AF:
0.636
Gnomad4 ASJ exome
AF:
0.614
Gnomad4 EAS exome
AF:
0.459
Gnomad4 SAS exome
AF:
0.645
Gnomad4 FIN exome
AF:
0.626
Gnomad4 NFE exome
AF:
0.559
Gnomad4 OTH exome
AF:
0.563
GnomAD4 genome
AF:
0.537
AC:
81697
AN:
152042
Hom.:
22541
Cov.:
33
AF XY:
0.545
AC XY:
40516
AN XY:
74350
show subpopulations
Gnomad4 AFR
AF:
0.416
Gnomad4 AMR
AF:
0.624
Gnomad4 ASJ
AF:
0.640
Gnomad4 EAS
AF:
0.436
Gnomad4 SAS
AF:
0.650
Gnomad4 FIN
AF:
0.630
Gnomad4 NFE
AF:
0.569
Gnomad4 OTH
AF:
0.569
Alfa
AF:
0.413
Hom.:
1109
Bravo
AF:
0.529
Asia WGS
AF:
0.572
AC:
1990
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanNov 12, 2023This variant is classified as Benign based on local population frequency. This variant was detected in 68% of patients studied by a panel of primary immunodeficiencies. Number of patients: 65. Only high quality variants are reported. -
Benign, no assertion criteria providedclinical testingClinical Genetics Laboratory, Department of Pathology, Netherlands Cancer Institute-- -
Ataxia-telangiectasia syndrome Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 01, 2021- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Hereditary breast ovarian cancer syndrome Benign:1
Benign, criteria provided, single submitterclinical testingNational Health Laboratory Service, Universitas Academic Hospital and University of the Free StateApr 19, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
0.13
DANN
Benign
0.65

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs664982; hg19: chr11-108225483; COSMIC: COSV53733871; API